ID: ALA289281

Max Phase: Preclinical

Molecular Formula: C8H9O7P

Molecular Weight: 248.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(O)c(O)c(CP(=O)(O)O)c1

Standard InChI:  InChI=1S/C8H9O7P/c9-6-2-4(8(11)12)1-5(7(6)10)3-16(13,14)15/h1-2,9-10H,3H2,(H,11,12)(H2,13,14,15)

Standard InChI Key:  FBADBTVHLVCADM-UHFFFAOYSA-N

Associated Targets(non-human)

aroB 3-dehydroquinate synthase (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.13Molecular Weight (Monoisotopic): 248.0086AlogP: 0.47#Rotatable Bonds: 3
Polar Surface Area: 135.29Molecular Species: ACIDHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.73CX Basic pKa: CX LogP: -0.44CX LogD: -5.91
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.39Np Likeness Score: 0.84

References

1. Chandran SS, Frost JW..  (2001)  Aromatic inhibitors of dehydroquinate synthase: synthesis, evaluation and implications for gallic acid biosynthesis.,  11  (12): [PMID:11412967] [10.1016/s0960-894x(01)00065-8]

Source